Low

Can Indians invest directly in stocks in Japan, Korea, and Taiwan? Rules, restrictions, costs and taxes explained

The article explains that Indians can invest directly in Japan, South Korea, and Taiwan stocks only through global brokers that accept Indian residents, noting that direct access may involve rules, costs, and taxes. It also cites market-cap figures as of June 1: South Korea $5.04 trillion, Taiwan $5.15 trillion, and India $4.84 trillion, highlighting the scale of these markets versus India.

1/10
2/10
Low
today/ongoing for Indian investors planning cross-border brokerage setup
neutral

Background

Educational explainer on whether Indian residents can directly invest in Japan, South Korea, and Taiwan equities, covering rules, restrictions, costs, and taxes.

Why it matters

No company-specific corporate event is described; the only “market” content is relative equity market capitalization rankings and practical access considerations.

Market relevance

Relevant for investors’ ability to allocate capital internationally, but not a tradable catalyst for any US-listed company.

Market effects

Primarily affects retail access mechanics (brokers, costs, taxes), not specific listed issuers or sectors.

Potentially marginally increases retail participation interest in Japan/Korea/Taiwan markets, but no direct company-level catalyst is identified.

Reinforces cross-border investing friction; likely limited immediate impact on US-listed equities.

Alternative perspectives

Even if access improves, flows are unlikely to be large enough to move individual stocks; the article is more a guide than a catalyst.

Actual investability depends on broker acceptance, tax treaty handling, and execution/FX costs—none are quantified for any specific issuer.

Key entities

  • Japan, South Korea, Taiwan equity markets

    Discussed as destinations for direct retail investing; no individual listed company is the subject of the article.

  • Global brokers / ETFs

    The article’s main decision point is using a global broker for direct ownership versus ETFs for easier access.

Related articles

$GOOGLLow

Alphabet is Raising $84.75 Billion to Win the AI Wars. Should Investors Celebrate or Worry?

Alphabet, Google’s parent, announced an $84.75 billion equity offering to fund artificial intelligence investments. The company said it plans to spend $180 billion to $190 billion on AI this year, citing progress from Gemini across products and cloud, plus a deal with Apple to power next-gen models. Investors face potential dilution, though the raise is about 2% of its $4.3 trillion market cap.

$CIFRLow

Cipher Digital (CIFR) Mimics Market Rally as US-Iran Tensions Subside

Cipher Digital Inc. (NASDAQ:CIFR) rose for a second day, up 8.26% to close at $24.50, tracking a broader market rally tied to easing US-Iran tensions, according to the article. Earlier this week, it raised $800 million via 5-year senior secured notes yielding 6%. Proceeds fund its Stingray data center (15-year AWS lease) and related costs, with notes guaranteed by Cipher Stingray.

$DUKLow

Duke Energy (DUK) Receives More DOE Grants

Duke Energy said the U.S. Department of Energy selected it for a grant of up to $61.8 million to refurbish and improve reliability of coal-fired plants in Kentucky and North Carolina. The company will negotiate final amounts for East Bend Station (up to $33.4 million) and Roxboro units 2 and 3 (up to $28.4 million). Duke said DOE funding for its projects totals nearly $96 million.

$BBWLow

Bath & Body Works shares update customers will love

Bath & Body Works’ shares have struggled in 2026 as investors weigh slowing sales growth and category pressures, according to the article. In Q1, the company reported net sales of $1.4 billion, down 3% year over year, and said consumer uncertainty and a challenging retail environment persisted. Body care declined in the mid-teens, Retail Dive reported. CEO Daniel Heaf said its multi-year transformation is on track.

$ACNTMed

Ascent Industries Pitches Pure-Play Chemicals Shift, Buybacks and Growth Runway

Ascent Industries (NASDAQ:ACNT) said it is intentionally shifting revenue from custom manufacturing toward product sales, which it expects to be more predictable and margin accretive. Product sales rose from ~10% of sales in 2023 to ~27% in 2024 and ~30% last year. Management cited $7M and $10M net-new business from recent customer wins, underutilized assets (~45% utilization), and a $14M Midwest Graphic Sales acquisition (closed early May) with $10.8M revenue and ~$2M adjusted EBITDA.

$RKDAMedAI 9/10

Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Arcadia Biosciences (Nasdaq: RKDA) said it closed a $4 million private placement under Nasdaq rules, selling 3,883,496 shares of common stock (or pre-funded warrants) plus Series A-1 and A-2 preferred investment options to buy up to 3,883,496 shares each at $1.03/share. Gross proceeds were about $4 million. H.C. Wainwright & Co. was placement agent; proceeds will fund working capital and general corporate purposes.